Compliance & Legal Overview
Biopunk Peptides — Compliance & Legal Overview
Effective Date: 2026-07-31
Last Updated: 2026-07-31
Version: 1.1
6.1 Compliance Snapshot
| Attribute | Value |
|---|---|
| Effective Date | 2026-07-31 |
| Last Updated | 2026-07-31 |
| Company | Biopunk Labs LLC |
| State of Formation | Wyoming, USA |
| Primary Classification | Laboratory research and analytical purposes only |
| Destinations | All 50 U.S. states (retail); wholesale/international by written agreement |
| Payment Methods | Card / Apple Pay / Google Pay via Verified Crypto Checkout; cryptocurrency via NoWPayments |
| Age Requirement | 21+ (verified at checkout) |
| Order Change Window | 12 hours from payment |
| Governing Law | State of Wyoming, USA |
| Support | [email protected] |
6.2 Company Legal Structure
Biopunk Peptides is operated by Biopunk Labs LLC, a Wyoming Limited Liability Company registered and in good standing. Our business operates exclusively as a supplier of research-grade peptides and laboratory materials.
We are not a pharmacy, compounding facility, or health product distributor, and we do not market products for human or veterinary use.
6.3 Intended Use of Products
All products sold by Biopunk Peptides are strictly for laboratory research and analytical purposes.
They are:
Not approved by the U.S. Food and Drug Administration (FDA)
Not intended for human or animal consumption or use
Not for therapeutic, diagnostic, or medical purposes
Not dietary supplements, cosmetics, or medical devices
6.4 FDA Compliance — Research Use Only (RUO)
All products are labeled in accordance with 21 CFR 809.10(c)(2)(i) as Research Use Only (RUO). They are not intended for clinical investigations or diagnostic applications.
RUO-specific labeling includes:
“For Research Use Only — Not for Human or Animal Use”
No dosing, reconstitution, or administration instructions provided
Biopunk’s RUO position is intended to prevent product misclassification, misuse, or interpretation as clinical, therapeutic, diagnostic, or consumer-use products. The full RUO Policy is published as a separate document and is incorporated by reference into these compliance representations.
Where RUO is communicated:
Product labels and packaging
Website product pages and descriptions
Checkout disclaimers
All policy pages
Packaging inserts and shipment documentation
6.5 Product Testing & Retention
Product identity and purity are supported through analytical testing.
Quality verification includes analytical testing where applicable
Certificates of Analysis (COAs) are available for relevant products
Testing methodology includes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) where specified
COA access.
COAs are available on individual product pages where applicable
Customers may request COA documentation via [email protected]
Every shipment includes documentation confirming Research Use Only status
Retention library. Biopunk maintains a retention library of sealed vials from each production batch for a defined retention window. Retention samples are used exclusively for dispute-resolution testing (see Returns & Refund Policy §5.4) and for internal quality assurance. Retention samples are not sold and are not returned to inventory.
6.6 Packaging, Labeling, and Shipment
Products ship from Biopunk’s U.S. warehouse in Milwaukee, Wisconsin in tamper-evident, RUO-labeled packaging.
Packaging excludes medically symbolic or injection-related language
COAs and RUO disclaimers are included with all shipments where applicable
Shipments use plain, unbranded exterior boxes without any external reference to Biopunk Peptides or product contents
No branding suggests medical or therapeutic use
6.7 Communication & Customer Support Policy
Biopunk’s support team does not provide guidance on:
Dosing
Preparation or reconstitution
Injection or administration
Storage for consumption
Safety or efficacy for human or animal use
Biopunk’s support team can assist with:
Product catalog and ordering questions
COA availability and documentation requests
Shipping status and logistics
Account and payment inquiries
General policy questions
6.8 Misuse Monitoring & Enforcement
Biopunk actively monitors for product misuse and takes appropriate corrective measures. Actions may include:
Canceling suspicious or non-research orders
Restricting or suspending customer accounts
Refusing future service to non-compliant individuals
Disclaiming responsibility for third-party content
Cooperating with authorities where lawful legal process requires disclosure (see RUO Policy §3.9)
All customers agree at checkout to indemnify Biopunk Peptides from liability arising out of misuse of products.
6.9 Regulatory & Platform Cooperation
This Compliance & Legal Overview is maintained to support:
Payment processors (NoWPayments; Verified Crypto Checkout)
Shipping partners (USPS; FedEX)
Regulatory authorities
Financial institutions and compliance audits
Industry transparency standards
This page is published publicly to promote trust, transparency, and proper product classification.
6.10 Intellectual Property
The Biopunk name, logo, product names, website content, and associated marks are the intellectual property of Biopunk Labs LLC. No rights in these marks or content are conveyed by the purchase of products or by use of the website. Unauthorized reproduction, redistribution, or commercial use of Biopunk trademarks or website content is prohibited.
6.11 Third-Party Content
Biopunk is not responsible for third-party content, including social media mentions, product reviews, blog posts, or content published on platforms outside biopunkpeptides.com, which may be inaccurate, misleading, or unlawful. Customers and researchers should verify any claims made by third parties against Biopunk’s official policies and product documentation.
6.12 Compliance Checklist
| Requirement | Status |
|---|---|
| Research Use Only labeling on all products | ✓ Applied |
| RUO designation on all website pages | ✓ Applied |
| No dosing, reconstitution, or administration guidance | ✓ Enforced |
| No human or animal use positioning | ✓ Enforced |
| No therapeutic or diagnostic claims | ✓ Enforced |
| COA documentation available | ✓ Available on request |
| Age verification (21+) | ✓ Required at checkout |
| 12-hour order-change window | ✓ Enforced |
| Retention library maintained for dispute resolution | ✓ Enforced (Returns Policy §5.4) |
| Governing law and arbitration provisions | ✓ Enforced (T&C §1.15, §1.16) |
| Payment finality disclosure to card buyers | ✓ Enforced (Returns Policy §5.7) |
| Wholesale / international carve-out with KYC and export-control review | ✓ Enforced (Shipping Policy §4.7; T&C §1.10) |
| Legal entity registered (Wyoming LLC) | ✓ Biopunk Labs LLC |
| Shipping documentation (RUO-labeled) | ✓ Applied |
| Tamper-evident, plain, unbranded packaging | ✓ Applied |
6.13 Governing Law and Dispute Resolution
This Compliance & Legal Overview is governed by the laws of the State of Wyoming, USA, without regard to conflict-of-law principles. Any dispute arising out of or relating to this document or Biopunk’s compliance representations is subject to the arbitration, class-action waiver, and forum provisions in §1.16 of the Biopunk Peptides Terms & Conditions, which are incorporated by reference into this document.
6.14 Contact Information
For compliance-related inquiries, documentation requests, or policy questions:
Email: [email protected]
Website: biopunkpeptides.com
Mailing Address:
Biopunk Labs LLC
30 N Gould St. #36251
Sheridan, WY 82801
Entity: Biopunk Labs LLC, Wyoming
APPENDIX A: LEGAL PAGES
| Page | URL | Purpose |
|---|---|---|
| Terms & Conditions | /terms | Purchase agreement, liability, prohibited uses, arbitration |
| Privacy Policy | /privacy | Data collection, use, user rights |
| Research Use Only (RUO) Policy | /ruo | Laboratory-use restrictions, qualified buyer requirements |
| Shipping Policy | /shipping-policy | Carrier, timelines, tracking, liability, restrictions |
| Returns & Refund Policy | /returns | Eligibility, claim process, retention-based testing, refund methods |
| Compliance & Legal Overview | /compliance | Company structure, FDA alignment, retention library, enforcement |
APPENDIX B: KEY REGULATORY REFERENCES
| Citation | Description |
|---|---|
| 21 CFR 809.10(c)(2)(i) | FDA regulation for Research Use Only labeling |
| FD&C Act (21 U.S.C. § 301 et seq.) | Food, Drug & Cosmetic Act |
| TSCA (15 U.S.C. § 2601 et seq.) | Toxic Substances Control Act |